Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?
Abstract A new coronavirus respiratory disease (COVID-19) caused by the SARS-CoV-2 virus, surprised the entire world, producing social, economic, and health problems. The COVID-19 triggers a lung infection with a multiple proinflammatory cytokine storm in severe patients. Without effective and safe...
Main Authors: | Rodrigo N. Riedel, Antonio Pérez-Pérez, Víctor Sánchez-Margalet, Cecilia L. Varone, Julieta L. Maymó |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-021-02216-w |
Similar Items
-
Case report of amniotic membrane derived-stem cells treatment for feline chronic obstructive pulmonary disease
by: Taeho Kim, et al.
Published: (2021-12-01) -
Isolation, Characteristics, Differentiation and Exploitation of Human Amnion Mesenchymal Stem Cells
by: Fiona Macniesia Thomas, et al.
Published: (2022-12-01) -
Effect of Mother’s Age and Pathology on Functional Behavior of Amniotic Mesenchymal Stromal Cells—Hints for Bone Regeneration
by: Maria Matteo, et al.
Published: (2019-08-01) -
The effect of amniotic membrane extract on umbilical cord blood mesenchymal stem cell expansion: is there any need to save the amniotic membrane besides the umbilical cord blood?
by: Zahra Vojdani, et al.
Published: (2016-01-01) -
CONSTANT MURLEY SCORE ON PATIENTS POST SUPRASPINATUS RECONSTRUCTION WITH MEMBRANE AMNION COMPOSITE AND FAT TISSUE ALLOGENIC MESENCHYMAL STEM CELL AUGMENTATION
by: Heri Suroto, et al.
Published: (2019-12-01)